DOCUMENT RESOURCES FOR EVERYONE
Documents tagged
Bevacizumab: Antiangiogenic therapy for breast cancer: where do we stand? Fortunato Ciardiello Division of Medical Oncology, Department of Clinical and.
Documents Bevacizumab: Antiangiogenic therapy for breast cancer: where do we stand? Fortunato Ciardiello...

Bevacizumab: Antiangiogenic therapy for breast cancer: where do we stand? Fortunato Ciardiello Division of Medical Oncology, Department of Clinical and Experimental Medicine,…

Copyright © 2010, Research To Practice, All rights reserved. Part II: Ovarian Cancer Monday, September 27, 2010 7:30 PM - 8:30 PM ET Monday Night with.
Documents Copyright © 2010, Research To Practice, All rights reserved. Part II: Ovarian Cancer Monday,...

Deborah K Armstrong, MD Associate Professor of Oncology, Gynecology and Obstetrics The Sidney Kimmel Comprehensive Cancer Center The Johns Hopkins University Baltimore, Maryland…

Monday Night with Research To Practice: An 8-Part Live CME Webcast Series
Documents Monday Night with Research To Practice: An 8-Part Live CME Webcast Series

Deborah K Armstrong, MD Associate Professor of Oncology, Gynecology and Obstetrics The Sidney Kimmel Comprehensive Cancer Center The Johns Hopkins University Baltimore, Maryland…

Highlights in the Management of Ovarian Cancer Roma 5 ottobre 2007 “Novel therapeutic approaches" Sandro Pignata National Cancer Institute Naples Italy.
Documents Highlights in the Management of Ovarian Cancer Roma 5 ottobre 2007 “Novel therapeutic approaches"....

Highlights in the Management of Ovarian Cancer Roma 5 ottobre 2007 âNovel therapeutic approaches" Sandro Pignata National Cancer Institute Naples Italy Results in Advanced…

1 Phase III Trial of Bevacizumab in the Primary Treatment of Advanced Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer: A Gynecologic Oncology.
Documents 1 Phase III Trial of Bevacizumab in the Primary Treatment of Advanced Epithelial Ovarian, Primary...

* Phase III Trial of Bevacizumab in the Primary Treatment of Advanced Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer: A Gynecologic Oncology Group (GOG)…

Final analysis of a randomized phase II trial of bevacizumab and gemcitabine plus cetuximab or erlotinib in patients with advanced pancreatic cancer Hedy.
Documents Final analysis of a randomized phase II trial of bevacizumab and gemcitabine plus cetuximab or...

Final analysis of a randomized phase II trial of bevacizumab and gemcitabine plus cetuximab or erlotinib in patients with advanced pancreatic cancer Hedy Lee Kindler, Tara…

Disclosures
Documents Disclosures

Final analysis of a randomized phase II trial of bevacizumab and gemcitabine plus cetuximab or erlotinib in patients with advanced pancreatic cancer Hedy Lee Kindler, Tara…

Popular Categories
Relevant Tags